SCHEMBL29385685

SCHEMBL29385685

O=Cc1cc(OCc2ccccc2)cc2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.54
RAB9A P51151 5/20 0.51
NPC1 O15118 4/20 0.51
MAOA P21397 1/20 0.51
MAOB P27338 1/20 0.51
MAPT P10636 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CCNB2 O95067 2/20 0.47
CDK1 P06493 2/20 0.47
CDK4 P11802 2/20 0.47
CCNB1 P14635 2/20 0.47
CCND1 P24385 2/20 0.47
CCNB3 Q8WWL7 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP19A1 P11511 1/20 0.44
ERN1 O75460 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26124646 1.00 ALOX5 (0.54) ALOX5RAB9ANPC1MAOAMAOB
SCHEMBL13523860 0.84 MAOB (0.51) ALOX5RAB9ANPC1MAOAMAOB
SCHEMBL21822484 0.82 RAB9A (0.41) ALOX5RAB9ANPC1MAPTSMN1; SMN2
SCHEMBL23796751 0.81 MAOB (0.57) ALOX5MAOAMAOBL3MBTL1CCNB2
SCHEMBL19660281 0.78 MAOA (0.51) ALOX5RAB9ANPC1MAOAMAOB
SCHEMBL8050543 0.78 GAA (0.52) RAB9ANPC1MAPTSMN1; SMN2L3MBTL1
SCHEMBL8327914 0.78 MAOA (0.61) ALOX5RAB9ANPC1MAOAMAOB
SCHEMBL13886669 0.78 KMT2A (0.49) RAB9ANPC1MAPTL3MBTL1KMT2A
SCHEMBL27432917 0.77 MEN1 (0.49) ALOX5RAB9ANPC1MAOAMAOB
SCHEMBL4483973 0.77 ALOX5 (0.59) ALOX5RAB9ANPC1MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057744-B Process for preparing KRAS G12C inhibitors imidazotriazines and pyrrolopyrimidine derivatives 百济神州(北京)生物科技有限公司 2025-01-17 CN disclosed
CN-114057744-A Process for preparing imidazotriazine and pyrrolopyrimidine derivatives as inhibitors of KRAS G12C 百济神州(北京)生物科技有限公司 2022-02-18 CN disclosed
WO-2022028492-A1 IMIDAZOTRIAZINE AND PYRROLOPYRIMIDINE DERIVATIVES AS KRAS G12C INHIBITORS BEIGENE, LTD. (KY) 2022-02-10 WO disclosed